The Imperial College London Diabetes Centre (ICLDC), part of the M42 group, has announced it will open a dedicated facility in Madinat Zayed to provide comprehensive care for diabetes and endocrine patients.
Set to open in the second half of this year, the new centre in Al Dhafra will provide targeted prevention and intervention for more than 6,000 diabetes sufferers in the region, cutting travel time by more than 75 per cent.
It will be equipped with the latest diagnostic and management facilities supported by a multi-specialty team, with “state-of-the-art” outpatient services, providing specialised care for diabetes and endocrine-related complications.
It was shared that the flagship ICLDC in Abu Dhabi currently serves around 9 per cent of the Al Dhafra patient population, while the facility in Madinat Zayed will provide greater access to those across the Al Dhafra region, including residents of Liwa, Mirfa, Gayathi, Ruwais, and Tarif.
ICLDC will also continue to promote preventive solutions for Type 2 diabetes, with an extensive community outreach programme including:
- Workshops,
- Health screenings,
- Educational programmes for schools and organisations, and
- The promotion of an active lifestyle and healthy eating.
Hasan Jasem Al Nowais, Managing Director, and Group Chief Executive Officer, M42, said: “M42 is committed to providing world-class preventive and personalised health solutions that enable individuals to put their health back in their own hands. As a leader in diabetes and endocrine management and prevention, the Imperial College London Diabetes Centre is positively impacting lives across the UAE. Expanding our one-stop services to Al Dhafra presents an opportunity to serve a much greater number of UAE residents with an innovative model that provides premium, tech-enabled health solutions that result in tangible positive clinical outcomes.”
Dr. Mai Al Jaber, Chief Executive Officer of ICLDC, commented: “Today, the need for accessible and comprehensive diabetes care has never been more apparent. Serving more of the Al Dhafra population is an honour and a duty we are fully committed to. Our aim is to provide patients with the best patient-centric and comprehensive diabetes and endocrinology solutions, under one roof and closer to home.”
ICLDC’s Madinat Zayed facility will be the fourth dedicated facility in the UAE, in addition to a satellite clinic based in Mubadala Health Dubai, which offers integrated diabetes and endocrine treatment services.